These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10194091)

  • 1. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
    Grinspoon S; Corcoran C; Anderson E; Hubbard J; Stanley T; Basgoz N; Klibanski A
    Clin Infect Dis; 1999 Mar; 28(3):634-6. PubMed ID: 10194091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of testosterone in the AIDS wasting syndrome.
    Corcoran C; Grinspoon S
    AIDS Clin Care; 1999 Apr; 11(4):25-6, 33-4. PubMed ID: 11366208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
    Abrams D
    AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
    J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
    Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
    Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
    Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
    J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
    Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement for hypogonadism: clinical findings and best practices.
    Hengge UR
    AIDS Read; 2003 Dec; 13(12 Suppl):S15-21. PubMed ID: 14959695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.
    Roubenoff R; Grinspoon S; Skolnik PR; Tchetgen E; Abad L; Spiegelman D; Knox T; Gorbach S
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E138-45. PubMed ID: 12067854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.
    Grinspoon S; Corcoran C; Stanley T; Baaj A; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):60-5. PubMed ID: 10634364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of pharmacologically induced hypogonadism on mood in healthy men.
    Schmidt PJ; Berlin KL; Danaceau MA; Neeren A; Haq NA; Roca CA; Rubinow DR
    Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting.
    Esposito JG; Thomas SG; Kingdon L; Ezzat S
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E494-503. PubMed ID: 15886228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.